Aaron J. Morris

Antibody Opsonization of a TLR9 Agonist–Containing Virus-like Particle Enhances In Situ Immunization

G. Weiner, A. Krieg, S. Blackwell, 2020, The Journal of Immunology.

Investigational Assay for Haplotype Phasing of the Huntingtin Gene

N. Svrzikapa, S. Levy, K. Longo, 2020, Molecular therapy. Methods & clinical development.

Dependence on the Pyrimidine Biosynthetic Enzyme DHODH Is a Synthetic Lethal Vulnerability in Mutant KRAS-Driven Cancers.

Q. Gao, I. Cornella-Taracido, C. García-echeverría, 2018, Cell chemical biology.

Overcoming PD-1 Blockade Resistance with CpG-A Toll-Like Receptor 9 Agonist Vidutolimod in Patients with Metastatic Melanoma

Katie M. Campbell, D. Davar, J. Kirkwood, 2021, Cancer discovery.

Abstract 2243: Clonogenic 3D high throughput screening in mutant KRAS dependent cancer cells - a chemogenomic approach.

I. Cornella-Taracido, C. García-echeverría, M. P. Castaldi, 2013 .